← All trials
NCT04301466
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 16, 2014
- Primary completion
- May 30, 2018
- Completion date
- May 30, 2018
- First posted
- Mar 10, 2020
- Last posted
- Mar 11, 2020
- Enrollment
- 362
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Peking UniversityLead sponsor
- Peking UniversityReponsible party - principal investigator
- Shanxi Zhendong pharmaceutical Co. LTD.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.